Furthermore, it inhibited the proliferation of lung fibroblasts through miR-203/Cav2, thereby preventing the excessive deposition of ECM and reducing idiopathic pulmonary fibrosis (IPF) [53]. The gene discussed is CAV2; the disease is pulmonary fibrosis.